Development of a research capacity building programme on cancer with and for Ukraine

Expected Outcome:This topic aims to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care.To this end, proposals should aim at delivering results that are directed and tailored towards and contribute to all of the following expected outcomes:Researchers, clinicians and health care professionals will have access to improved research capacities, supporting better integration with care.Patients and citizens will have access to improved screening, diagnostics and treatments, while increasing their participation in clinical trials. Scope:Ukraine has a very high cancer burden with more than 155,000 new diagnoses every year[1]. The country has also one of the highest childhood cancer mortality rates globally[2]. Disparities in access and quality of cancer care in Ukraine were high before Russia's unprovoked aggression and worsened because of the conflict, which has also led to increased cancer mortality and morbidity, due to discontinuation of treatments and shortage of medical supplies.Proposals should address all of the following:A research capacity-building programme should be set up between EU Member States/Associated Countries and Ukraine, in order to support Ukraine to develop or to further improve research & innovation-related capacities of future or existing Cancer Infrastructures.The capacity building programme should include the following components:Development of a joint-research training programme, including distance-learning modulesTwinning research activities, including staff-exchange for the implementation of targeted research projects and access to cutting-edge services The capacity building programme should cover at least the following areas;Enhanced involvement in quality scientific research, including development and implementation of clinical trials and other epidemiol